Status: current, Defined. Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3786628017 | Product containing cilastatin and imipenem and relebactam in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3786629013 | Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Is a | Cilastatin- and imipenem- and relebactam-containing product | true | Inferred relationship | Some | ||
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Has active ingredient | Relebactam | true | Inferred relationship | Some | 2 | |
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Has active ingredient | Cilastatin | true | Inferred relationship | Some | 3 | |
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Has active ingredient | Imipenem | true | Inferred relationship | Some | 1 | |
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Is a | Cilastatin- and imipenem-containing product in parenteral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Cilastatin and imipenem and relebactam only product in parenteral dose form | Is a | True | Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set